This section covers the managerial aspects in the Pharma industry.
Exelixis Inctoday announced results from a phase 1 trial of cabozantinib in combination with either nivolumab or nivolumab plus ipilimumab in patients with refractory genitourinary tumors The primary endpoint of the trial is to determine the dose limiting toxicity DLT and recommended phase 2 doses o..
AstraZeneca today announced positive results from its Phase III OlympiAD trial comparing LYNPARZA olaparib tablets 300mg twice daily to physicians choice of a standard of care chemotherapy in the treatment of patients with HER2negative metastatic breast cancer harboring germline BRCA1 or BRCA2 mutat..
CPhI Russia IPhEB cphirussia returns to the Russian capital taking place at the JSC VDNH VVC Moscow 28th30th March as the Governments Pharma 2020 plan continues to stimulate demand for international pharmaceutical ingredients manufacturing and packaging equipment The events 4th edition will see th..
Innovations and Advancements in Drug Discovery Changing the Topography of Pharmaceutical Industry Rapidly The demand for drug discovery technologies in the region of North America also gains from highincome population collectively promising healthy potential returns on investments due to high ado..
Boehringer Ingelheim today announced that the US Food and Drug Administration FDA approved tiotropium Respimat marketed as SPIRIVA Respimat for the longterm oncedaily maintenance treatment of people with asthma aged 6 years and older who continue to experience symptoms despite their other maintenanc..
Ascendis Pharma AS a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs in rare diseases today announced the publication of its previously presented pediatric phase 2 trial of TransCon Growth Hormone in the Journal of Clinical Endocr..
Ionis Pharmaceuticals Incand Akcea Therapeutics a whollyowned subsidiary of Ionis Pharmaceuticals Inc announced today they have closed on their exclusive worldwide option and collaboration agreement with Novartis to develop and commercialize AKCEAAPOaLRx and AKCEAAPOCIIILRx following clearance under..
Clintec today announces the launch of its new brand identity reflected in their newly created website This in part marks Clintecs 20th anniversary and the achievement of significant milestones following another year of substantial growth together with a succession of key appointments that have enha..
Pharmapack Europe organised by UBM EMEA closed its 2017 edition celebrating its 20 years as the leading European event for pharmaceutical packaging and drug delivery devices The top trends that emerged from the twoday event included patient centricity traceability innovation compliance and adheren..
In a report published today in Nature Sterile protection against human malaria by chemoattenuated PfSPZ vaccine investigators from the University of Tbingen reported all nine subjects 100 immunized with three doses of Sanaria PfSPZCVac malaria vaccine in a recently completed clinical trial were prot..
CPhI South East Asia returns to the Jakarta International Expo in Indonesia for its sixth edition from the 22nd24th March 2017 as regional pharma companies expect robust growth The slowing pace of global markets and the increasing threat of a new protectionist wave is transforming the outlook of Sou..
Hutchison China MediTech Limited ChiMed AIMNasdaq HCM and AstraZeneca PLC AstraZeneca will present data from the ongoing Phase II clinical trial of savolitinib in patients with papillary renal cell carcinoma PRCC at the 2017 Genitourinary Cancers Symposium sponsored by the American Society of Clinic..
Theratechnologies Inc Theratechnologies TSX TH announced today that additional secondary efficacy and safety endpoint results from the 24week ibalizumab Phase III trial TMB301 were presented at a latebreaker session at the Conference on Retroviruses and Opportunistic Infections CROI 2017 Preliminary..
Armetheon Inc a specialty pharmaceutical company developing novel small molecule drugs for cardiovascular diseases today announced the issuance on January 24 2017 by the US Patent and Trademark Office USPTO of a new patent covering the company39s novel oral antiarrhythmic budiodarone the only known ..
MabVax Therapeutics Holdings Inc a clinical stage immunooncology drug development company today announced results from a preclinical study evaluating the potential benefits of using MabVax39s HuMab5B1antibody MVT5873 currently in Phase I clinical trials for the treatment of metastatic pancreatic can..
Under the patronage of HH Sheikh Hamdan bin Rashid al Maktoum Award for Medical Sciences 4TS International Conference 2017will take place on 16thFebruary at Conrad Hotel Dubai The 4TS International Conference is being organized in collaboration with the International Society of Endovascular Special..
Neurocrine Biosciences Inc and BIAL today announced that they have entered into an exclusive licensing agreement for the development and commercialization of opicapone in North America ONGENTYS opicapone is a oncedaily peripherallyacting highlyselective catecholOmethyltransferase inhibitor COMT inhi..
Acorda Therapeutics Inc today announced Phase 3 clinical data of CVT301 showing a statistically significant improvement in motor function in people with Parkinsons disease experiencing OFF periods CVT301 is an investigational inhalable formulation of levodopa Ldopa It is being studied as a treatment..
RepliCel Life Sciences Inc a clinical stage regenerative medicine company developing unique biologic products for pattern baldness and thinning hair aging and sundamaged skin and chronic tendon degeneration today announced the granting of two patents in Europe related to its multineedle dermal injec..
A drug first designed to prevent cancer cells from multiplying has a second effect it switches immune cells that turn down the body39s attack on tumors back into the kind that amplify it This is the finding of a study led by researchers from NYU Langone Medical Center and published recently in Cance..